Surgically Targeted Radiation Therapy (STaRT) for patients with operable brain tumors

Placed by a neurosurgeon at the time of resection, GammaTile Therapy gives patients a head STaRT in the fight against brain tumors, delaying tumor recurrence and potentially extending survival[1]

Limits radiation exposure to healthy tissue, minimizing side effects, including hair loss[1]

Assures 100% treatment compliance for all patients

Reduces patient and caregiver treatment burden in terms of time and travel

How does GammaTile Therapy work?

View our GammaTile Therapy animation.

Are you a clinician interested in GammaTile Therapy?

We can answer questions or schedule therapy training.


1. Garcia, M.A., Turner, A. & Brachman, D.G. The role of GammaTile in the treatment of brain tumors: a technical and clinical overview. J Neurooncol 166, 203–212 (2024).

GammaTile® is indicated as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms. For full product and safety information, refer to the Instructions for Use.